ArticleMedicine2019

A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Taoren Honghua Jian granule in patients with stable coronary artery disease.

Yiru Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.